ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
36.28
0.00%
US Tech 100
18,105.20
-1.53%
S&P 500
5,446.68
-1.37%
US Dollar vs CAD
1.38735
-0.05%
Bitcoin
64,729.30
-0.95%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Cidara Therapeutics Inc (CDTX)

  7. Cidara Therapeutics Inc (CDTX) News

CDTX

Cidara Therapeutics (CDTX)

Cidara Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CDTX
DateTimeSourceHeadlineSymbolCompany
07/31/20244:25PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:CDTXCidara Therapeutics Inc
07/29/20243:45PMEdgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:CDTXCidara Therapeutics Inc
07/29/20243:31PMEdgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:CDTXCidara Therapeutics Inc
07/19/20243:55PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CDTXCidara Therapeutics Inc
07/19/20243:54PMEdgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:CDTXCidara Therapeutics Inc
07/19/20243:54PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CDTXCidara Therapeutics Inc
07/19/20243:53PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CDTXCidara Therapeutics Inc
07/19/20243:40PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CDTXCidara Therapeutics Inc
07/19/20243:38PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CDTXCidara Therapeutics Inc
07/18/20243:31PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CDTXCidara Therapeutics Inc
06/03/20243:38PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:CDTXCidara Therapeutics Inc
06/03/20243:36PMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:CDTXCidara Therapeutics Inc
05/23/20243:59PMEdgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:CDTXCidara Therapeutics Inc
05/20/20243:04PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CDTXCidara Therapeutics Inc
03/04/20243:22PMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:CDTXCidara Therapeutics Inc
02/23/20243:05PMEdgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:CDTXCidara Therapeutics Inc
02/09/20247:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CDTXCidara Therapeutics Inc
12/22/20236:33AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CDTXCidara Therapeutics Inc
11/17/202312:22PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CDTXCidara Therapeutics Inc
11/16/20233:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CDTXCidara Therapeutics Inc
11/02/20233:08PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CDTXCidara Therapeutics Inc
11/02/20233:05PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CDTXCidara Therapeutics Inc
10/13/20239:36AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CDTXCidara Therapeutics Inc
09/21/202312:24PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CDTXCidara Therapeutics Inc
09/13/20233:24PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CDTXCidara Therapeutics Inc
09/13/20233:22PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CDTXCidara Therapeutics Inc
09/06/20237:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CDTXCidara Therapeutics Inc
08/14/20236:40PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CDTXCidara Therapeutics Inc
08/03/20233:03PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CDTXCidara Therapeutics Inc
08/03/20233:01PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CDTXCidara Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:CDTX

Your Recent History

USOTC
IDVV
International Endeavors (PK)
USOTC
AABB
Asia Broadband (PK)
AMEX
FOXO
FOXO Technologies
NASDAQ
AMRN
Amarin
NYSE
AMC
AMC Entertainment
USOTC
AHRO
Authentic (CE)
USOTC
VPLM
Voip Pal Com (QB)
NASDAQ
NVDA
NVIDIA
USOTC
SPZI
Spooz (PK)
NASDAQ
MULN
Mullen Automotive
USOTC
NSAV
Net Savings Link (PK)
NYSE
GME
GameStop
USOTC
SAPX
Seven Arts Entertainment (PK)
USOTC
CLNV
Clean Vision (QB)
NASDAQ
AMD
Advanced Micro Devices
USOTC
GRST
Ethema Health (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved